Alex Jackson

Alex Jackson

Company: Theragnostics

Job title: Head of Research & Development


DNA-Targeted Auger Electron-Emitting Radiopharmaceuticals: Following the Short- Range High LET Path 11:00 am

• The potential of short range high LET radioligand therapies is a hot topic as demonstrated by high scientific interest and investment in alpha-emitting drugs • Auger electrons are another class of high LET emission. The potential of an Auger emitter radioligand has been proposed for a several years, but combination with the correct protein…Read more

day: Day 2 Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.